COPD and the Risk of Tuberculosis--a Population-based Cohort Study

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2010 Apr 21

PMID 20405056

Citations 58

Authors

Malin Inghammar

Anders Ekbom

Gunnar Engstrom

Bengt Ljungberg

Victoria Romanus

Claes-Goran Lofdahl

Arne Egesten

Affiliations

Soon will be listed here.

Abstract

Background: Both chronic obstructive pulmonary disease (COPD) and tuberculosis (TB) primarily affect the lungs and are major causes of morbidity and mortality worldwide. COPD and TB have common risk factors such as smoking, low socioeconomic status and dysregulation of host defence functions. COPD is a prevalent co-morbid condition, especially in elderly with TB but in contrast to other diseases known to increase the risk of TB, relatively little is known about the specific relationship and impact from COPD on TB-incidence and mortality.

Methods And Findings: All individuals > or = 40 years of age, discharged with a diagnosis of COPD from Swedish hospitals 1987-2003 were identified in the Swedish Inpatient Register (n = 115,867). Records were linked to the Swedish Tuberculosis Register 1989-2007 and the relative risk of active TB in patients with COPD compared to control subjects randomly selected from the general population (matched for sex, year of birth and county of residence) was estimated using Cox regression. The analyses were stratified by year of birth, sex and county of residence and adjusted for immigration status, socioeconomic status (SES) and inpatient co-morbidities previously known to increase the risk of TB. COPD patients had a three-fold increased hazard ratio (HR) of developing active TB (HR 3.0 (95% confidence interval 2.4 to 4.0)) that was mainly dependent on an increased risk of pulmonary TB. In addition, logistic regression estimates showed that COPD patients who developed active TB had a two-fold increased risk of death from all causes within first year after the TB diagnosis compared to the general population control subjects with TB (OR 2.2, 95% confidence interval 1.2 to 4.1).

Conclusions: This population-based study comprised of a large number of COPD patients shows that these patients have an increased risk of developing active TB compared to the general population. The results raise concerns that the increasing global burden of COPD will increase the incidence of active TB. The underlying contributory factors need to be disentangled in further studies.

Citing Articles

Sequelae of Immunocompromised Host Pneumonia.

Salwen B, Mascarenhas E, Horne D, Crothers K, Zifodya J Clin Chest Med. 2025; 46(1):49-60.

PMID: 39890292 PMC: 11790256. DOI: 10.1016/j.ccm.2024.10.004.

Colliding Challenges Part 2: An Analysis of SARS-CoV-2 Infection in Patients with Extrapulmonary Tuberculosis Versus SARS-CoV-2 Infection Alone.

Mihuta C, Socaci A, Hogea P, Tudorache E, Mihuta M, Oancea C Medicina (Kaunas). 2025; 60(12.

PMID: 39768950 PMC: 11677740. DOI: 10.3390/medicina60122071.

Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence.

Matteelli A, Churchyard G, Cirillo D, den Boon S, Falzon D, Hamada Y PLOS Glob Public Health. 2024; 4(7):e0003306.

PMID: 38954723 PMC: 11218967. DOI: 10.1371/journal.pgph.0003306.

Colliding Challenges: An Analysis of SARS-CoV-2 Infection in Patients with Pulmonary Tuberculosis versus SARS-CoV-2 Infection Alone.

Mihuta C, Socaci A, Hogea P, Tudorache E, Mihuta M, Oancea C Medicina (Kaunas). 2024; 60(5).

PMID: 38793006 PMC: 11123355. DOI: 10.3390/medicina60050823.

Development and validation of a preliminary multivariable diagnostic model for identifying unusual infections in hospitalized patients.

Tekin A, Joghataee M, Rovati L, Truong H, Castillo-Zambrano C, Kushagra K Biomol Biomed. 2024; 24(5):1387-1399.

PMID: 38643478 PMC: 11379024. DOI: 10.17305/bb.2024.10447.

References

Ormerod L, Horsfield N, Green R . Tuberculosis treatment outcome monitoring: Blackburn 1988-2000. Int J Tuberc Lung Dis. 2002; 6(8):662-5. View

Aktogu S, Yorgancioglu A, Cirak K, Kose T, Dereli S . Clinical spectrum of pulmonary and pleural tuberculosis: a report of 5,480 cases. Eur Respir J. 1996; 9(10):2031-5. DOI: 10.1183/09031936.96.09102031. View

Bahceciler N, Nuhoglu Y, Nursoy M, Kodalli N, Barlan I, Basaran M . Inhaled corticosteroid therapy is safe in tuberculin-positive asthmatic children. Pediatr Infect Dis J. 2000; 19(3):215-8. DOI: 10.1097/00006454-200003000-00008. View

. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society.... Am J Respir Crit Care Med. 2000; 161(4 Pt 2):S221-47. DOI: 10.1164/ajrccm.161.supplement_3.ats600. View

Lienhardt C, Fielding K, Sillah J, Bah B, Gustafson P, Warndorff D . Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol. 2005; 34(4):914-23. DOI: 10.1093/ije/dyi100. View

Montnemery P, Adelroth E, Heuman K, Johannisson A, JOHANSSON S, Lindholm L . Prevalence of obstructive lung diseases and respiratory symptoms in southern Sweden. Respir Med. 1999; 92(12):1337-45. DOI: 10.1016/s0954-6111(98)90139-1. View

Lin H, Ezzati M, Chang H, Murray M . Association between tobacco smoking and active tuberculosis in Taiwan: prospective cohort study. Am J Respir Crit Care Med. 2009; 180(5):475-80. DOI: 10.1164/rccm.200904-0549OC. View

Bates M, Khalakdina A, Pai M, Chang L, Lessa F, Smith K . Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med. 2007; 167(4):335-42. DOI: 10.1001/archinte.167.4.335. View

Montnemery R, Nihlen U, Andersson M, Greiff L, Johannisson A, Nyberg P . Obstructive airways diseases, smoking and use of inhaled corticosteroids in southern Sweden in 1992 and 2000. Int J Tuberc Lung Dis. 2006; 10(5):490-8. View

10.

Sethi S, Murphy T . Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008; 359(22):2355-65. DOI: 10.1056/NEJMra0800353. View

11.

Shirakawa T, Enomoto T, Shimazu S, Hopkin J . The inverse association between tuberculin responses and atopic disorder. Science. 1997; 275(5296):77-9. DOI: 10.1126/science.275.5296.77. View

12.

Benfield T, Lange P, Vestbo J . COPD stage and risk of hospitalization for infectious disease. Chest. 2008; 134(1):46-53. DOI: 10.1378/chest.07-2933. View

13.

Schatz M, Patterson R, Kloner R, Falk J . The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med. 1976; 84(3):261-5. DOI: 10.7326/0003-4819-84-3-261. View

14.

Ludvigsson J, Otterblad-Olausson P, Pettersson B, Ekbom A . The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009; 24(11):659-67. PMC: 2773709. DOI: 10.1007/s10654-009-9350-y. View

15.

Barnes P, Celli B . Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009; 33(5):1165-85. DOI: 10.1183/09031936.00128008. View

16.

Salvi S, Barnes P . Chronic obstructive pulmonary disease in non-smokers. Lancet. 2009; 374(9691):733-43. DOI: 10.1016/S0140-6736(09)61303-9. View

17.

Maartens G, Wilkinson R . Tuberculosis. Lancet. 2007; 370(9604):2030-43. DOI: 10.1016/S0140-6736(07)61262-8. View

18.

Stenfors N . Physician-diagnosed COPD global initiative for chronic obstructive lung disease stage IV in Ostersund, Sweden: Patient characteristics and estimated prevalence. Chest. 2006; 130(3):666-71. DOI: 10.1378/chest.130.3.666. View

19.

Dye C . Global epidemiology of tuberculosis. Lancet. 2006; 367(9514):938-40. DOI: 10.1016/S0140-6736(06)68384-0. View

20.

Lindberg A, Jonsson A, Ronmark E, Lundgren R, Larsson L, Lundback B . Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration. 2005; 72(5):471-9. DOI: 10.1159/000087670. View